# FDA Inspection 1024425 - KEDPlasma, LLC - August 30, 2017

Source: https://www.keypedia.com/records/fda_inspections/kedplasma-llc/a79d8d2e-748d-407e-b4e0-9f0f6aa1fe8e
Source feed: FDA_Inspections

> FDA Inspection 1024425 for KEDPlasma, LLC on August 30, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1024425
- Company Name: KEDPlasma, LLC
- Inspection Date: 2017-08-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 919447 - 2015-03-26](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/0500de47-f3b9-478d-a219-f338b3189722)
- [FDA Inspection 841207 - 2013-07-23](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/53dc7f22-73e3-4842-ab1e-73c153ecbec2)
- [FDA Inspection 657771 - 2010-04-02](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/7459b5db-1817-4348-88b8-30e6d17a92e0)
- [FDA Inspection 649432 - 2010-01-21](https://www.keypedia.com/records/fda_inspections/kedplasma-llc/007e8a1e-0790-4645-873e-93143bec0f63)

Company: https://www.keypedia.com/companies/kedplasma-llc/2dd2e3f0-55e0-420e-9ce3-7c3066e64ec4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d